Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion
This is a single arm, interventional pilot study of using chlorhexidine irrigation
intra-operatively and post-operatively among patients undergoing radical cystectomy with
urinary diversion. The intervention comprises of using irrigation of ileal conduit or
ileal neo...
Age: 18 years - 66+
Gender: All
Auricular Neuromodulation for FESS
In this blinded prospective randomized control trial the researchers will investigate the
impact of cutaneous vagal nerve stimulation on surgical conditions in patients undergoing
functional and ascorbic sinus surgery (FESS). The device is an externally placed vagal
...
Age: 18 years - 66+
Gender: All
Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy
A randomized double-blind placebo controlled trial comparing the effect of a combined
ketorolac and lidocaine paracervical block with a standard lidocaine paracervical block
on procedure related pain with office hysteroscopies.
Age: 18 years - 66+
Gender: Female
Healing Track Clinical Trial
This is a randomized clinical trial to evaluate a digital pain reprocessing therapy (PRT)
intervention for chronic back pain (CBP).
The purpose of this research is to test whether a new digital treatment for chronic pain
works as well as traditional treatments for ...
Age: 21 - 70 years
Gender: All
Comprehensive Patient-Centered Home-based Care Coaching for COPD Self-management
The Icahn School of Medicine at Mount Sinai will conduct a randomized controlled trial of
a self-management support intervention for predominantly minoritized and low-income
adults with chronic obstructive pulmonary disease (COPD). The trial will focus on
comprehensi...
Age: 40 years - 66+
Gender: All
Asthma Symptom Perception Study
Asthma affects 8% of the United States population ages >60 years and causes considerable
harm: older adults are 4 times more likely to die from asthma and have twice the risk of
hospitalization. The burden of asthma is notably greater among minoritized older adults.
...
Age: 60 years - 66+
Gender: All
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight
The main purpose of this study is to demonstrate that when participants with moderate to
severe plaque psoriasis and obesity or overweight receive ixekizumab and tirzepatide
concomitantly administered, participants see improvement in their psoriasis and achieve
weigh...
Age: 18 years - 66+
Gender: All
TVNS in Long COVID-19
A prior open label study has shown that transcutaneous vagus nerve stimulation [tVNS] can
improve the health of some patients with postacute sequelae of SARS-CoV-2 infection
(PASC), severely affected enough to also fulfill criteria for myalgic encephalomyelitis /
chr...
Age: 21 - 70 years
Gender: All
Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression
The proposed study is a single-site, randomized, controlled clinical trial (RCT)
comparing ketamine-assisted psychotherapy (KAP) to a standard evidence-based regimen of
ketamine administered in a medical model without psychotherapy (KET). Eligible study
participants ...
Age: 18 - 90 years
Gender: All
Vestibular Innovation in Pain
The VIP trial will assess the effectiveness, tolerability, and durability of effect of
vestibulocortical stimulation (VCS) - a safe & cost-effective bedside technique - in
treating pain, fatigue & related symptoms using validated patient-reported outcomes. Data
from ...
Age: 18 - 99 years
Gender: All
A Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma
The purpose of this study is to define the safety of Ciltacabtagene Autoleucel
(Cilta-cel) and Talquetamab in participants with high-risk multiple myeloma (MM).
Age: 18 years - 66+
Gender: All
Deucravacitinib Rosacea
This will be a double-blind, randomized placebo-controlled study in which participants
will be randomized 2:1 to receive 6 mg deucravacitinib or placebo once daily for 8 weeks,
followed by an open label extension during which all participants will receive 6 mg
deucra...
Age: 18 years - 66+
Gender: All
Behavioral Therapy for Crohn's Disease
People living with Crohn's disease (CD) experience psychological and emotional symptoms,
in addition to known chronic and disabling physical symptoms, which prevent them from
living their life to the fullest (flourishing). Depression and anxiety are experienced by
30...
Age: 18 - 65 years
Gender: All
Ketamine for Methamphetamine Use Disorder
This study aims to determine whether treatment response with IV ketamine is superior to
treatment response with IV midazolam in adults with moderate to severe MUD.
The study design is a 12-week randomized, double-blind, controlled trial comparing
intravenous (IV) k...
Age: 18 - 65 years
Gender: All
The Prevent Coronary Artery Disease Trial
Despite increasing evidence that exposure to cardiovascular risk factors (CVRF) at an early age increases the prevalence of subclinical atherosclerosis and is associated with a greater risk of cardiovascular events later in life, there is a lack of randomized trial evid...
Age: 30 - 50 years
Gender: All
Lamivudine for Solid Tumors
Single arm, set dose clinical trial of Lamivudine for Relapsed Refractory Solid Tumors.
Accrual 6-24 patients, within 2 years, study completion within 3 years at Mount Sinai
Health System.
Primary Objective:
For Phase 1b to determine the safety and tolerabilit...
Age: 18 years - 66+
Gender: All
Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension
This is an extension study to evaluate the longer-term safety and efficacy of enlicitide
decanoate in adults with hypercholesterolemia who completed either study MK-0616-013
(NCT05952856), study MK-0616-017 (NCT05952869), or study MK-0616-018 (NCT06450366).
Age: 18 years - 66+
Gender: All
A Study of Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04)
This study is a substudy being conducted under one pembrolizumab umbrella master study
KEYMAKER-U04. The substudy will consist of 2 parts. Part 1 will evaluate the safety and
preliminary efficacy of sacituzumab tirumotecan plus enfortumab vedotin (EV). Part 2 will
be...
Age: 18 years - 66+
Gender: All
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis suppurativa (HS) is a chronic and often painful inflammatory skin disease
which includes the forming of lumps, abscesses and scars in areas of the skin such as
under the breasts, under armpits, inner thighs, groin and buttocks. This study will
compare lu...
Age: 16 years - 66+
Gender: All
A phase-3 study of a once-daily, oral treatment for those living with focal seizures
Randomized, Double-blind [study drug at 25mg, 15 mg or a placebo]
Duration: 7 months
Study visits: 9 study visits (7 Onsite and 2 telephone visits)
Study activities:
Blood, Urine and Stool sample collection
Complete surveys/questionnaires
Eye Exam, ECG
Compen...
Age: 18 years - 66+
Gender: N/A